Annotation (Toggle Detail/Summary View) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gene-Chemical Interaction Annotations
Gene-Chemical Interaction AnnotationsTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (R)-adrenaline | multiple interactions | ISO | RGD:737132 | 6480464 | Theophylline inhibits the reaction [Epinephrine results in increased activity of LIPE protein] | CTD | PMID:7155675 | (R)-adrenaline | increases expression | EXP | | 6480464 | Epinephrine results in increased expression of LIPE mRNA | CTD | PMID:10777495 | (R)-adrenaline | affects localization | ISO | RGD:3010 | 6480464 | Epinephrine affects the localization of LIPE protein | CTD | PMID:11160373 | (R)-adrenaline | increases activity | ISO | RGD:737132 | 6480464 | Epinephrine results in increased activity of LIPE protein | CTD | PMID:7155675 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:3010 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LIPE mRNA | CTD | PMID:19490992 | 2,6-dinitrotoluene | affects expression | ISO | RGD:3010 | 6480464 | 2,6-dinitrotoluene affects the expression of LIPE mRNA | CTD | PMID:21346803 | 26-hydroxycholesterol | multiple interactions | EXP | | 6480464 | LIPE protein promotes the reaction [27-hydroxycholesterol results in increased expression of STAR mRNA]; more ... | CTD | PMID:23362264 | 3',5'-cyclic AMP | increases activity | ISO | RGD:737132 | 6480464 | Cyclic AMP results in increased activity of LIPE protein | CTD | PMID:7155675 | aldehydo-D-glucosamine 6-phosphate | increases expression | EXP | | 6480464 | glucosamine 6-phosphate results in increased expression of LIPE mRNA | CTD | PMID:19427183 | all-trans-retinyl palmitate | increases hydrolysis | ISO | RGD:737132 | 6480464 | LIPE protein results in increased hydrolysis of retinol palmitate | CTD | PMID:16741517 | all-trans-retinyl palmitate | multiple interactions | ISO | RGD:737132 | 6480464 | PLIN3 protein inhibits the reaction [LIPE protein results in increased hydrolysis of retinol palmitate] | CTD | PMID:16741517 | ammonium chloride | affects expression | ISO | RGD:3010 | 6480464 | Ammonium Chloride affects the expression of LIPE mRNA | CTD | PMID:16483693 | ATP | increases activity | ISO | RGD:737132 | 6480464 | Adenosine Triphosphate results in increased activity of LIPE protein | CTD | PMID:7155675 | bucladesine | affects localization | ISO | RGD:3010 | 6480464 | Bucladesine affects the localization of LIPE protein | CTD | PMID:11160373 | bucladesine | increases expression | EXP | | 6480464 | Bucladesine results in increased expression of LIPE mRNA | CTD | PMID:23362264 | bucladesine | increases activity | EXP | | 6480464 | Bucladesine results in increased activity of LIPE protein | CTD | PMID:23362264 | bucladesine | multiple interactions | EXP | | 6480464 | [Bucladesine co-treated with LIPE protein] results in increased expression of ABCA1 protein; more ... | CTD | PMID:23362264 | clofibrate | increases expression | ISO | RGD:3010 | 6480464 | Clofibrate results in increased expression of LIPE mRNA | CTD | PMID:11328961 | cobalt dichloride | decreases expression | ISO | RGD:737132 | 6480464 | cobaltous chloride results in decreased expression of LIPE mRNA | CTD | PMID:12032628 | cobalt dichloride | decreases expression | ISO | RGD:737132 | 6480464 | cobaltous chloride results in decreased expression of LIPE mRNA | CTD | PMID:12032628 PMID:22917661 | desferrioxamine B | decreases expression | ISO | RGD:737132 | 6480464 | Deferoxamine results in decreased expression of LIPE mRNA | CTD | PMID:12032628 | diazoxide | increases phosphorylation | EXP | | 6480464 | Isoproterenol results in increased phosphorylation of LIPE protein | CTD | PMID:21042876 | diazoxide | affects localization | ISO | RGD:3010 | 6480464 | Isoproterenol affects the localization of LIPE protein | CTD | PMID:10894095 PMID:11160373 | diazoxide | affects localization | ISO | RGD:3010 | 6480464 | Isoproterenol affects the localization of LIPE protein | CTD | PMID:11160373 PMID:10894095 | diazoxide | multiple interactions | ISO | RGD:3010 | 6480464 | Papaverine inhibits the reaction [Isoproterenol results in increased activity of LIPE protein]; more ... | CTD | PMID:10894095 | diazoxide | increases activity | ISO | RGD:3010 | 6480464 | Isoproterenol results in increased activity of LIPE protein | CTD | PMID:10894095 | diazoxide | multiple interactions | EXP | | 6480464 | Sirolimus promotes the reaction [Isoproterenol results in increased phosphorylation of LIPE protein] | CTD | PMID:21042876 | dichlorine | multiple interactions | ISO | RGD:3010 | 6480464 | [Ozone co-treated with Chlorine] results in increased expression of LIPE mRNA | CTD | PMID:18636392 | dioxygen | decreases expression | ISO | RGD:737132 | 6480464 | Oxygen deficiency results in decreased expression of LIPE mRNA | CTD | PMID:12032628 | ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of LIPE mRNA | CTD | PMID:22173916 | ethanol | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Ethanol results in increased expression of LIPE mRNA] | CTD | PMID:22173916 | isoprenaline | increases phosphorylation | EXP | | 6480464 | Isoproterenol results in increased phosphorylation of LIPE protein | CTD | PMID:21042876 | isoprenaline | affects localization | ISO | RGD:3010 | 6480464 | Isoproterenol affects the localization of LIPE protein | CTD | PMID:10894095 PMID:11160373 | isoprenaline | multiple interactions | ISO | RGD:3010 | 6480464 | Papaverine inhibits the reaction [Isoproterenol results in increased activity of LIPE protein]; more ... | CTD | PMID:10894095 | isoprenaline | affects localization | ISO | RGD:3010 | 6480464 | Isoproterenol affects the localization of LIPE protein | CTD | PMID:11160373 PMID:10894095 | isoprenaline | increases activity | ISO | RGD:3010 | 6480464 | Isoproterenol results in increased activity of LIPE protein | CTD | PMID:10894095 | isoprenaline | multiple interactions | EXP | | 6480464 | Sirolimus promotes the reaction [Isoproterenol results in increased phosphorylation of LIPE protein] | CTD | PMID:21042876 | N-nitrosodiethylamine | increases expression | ISO | RGD:3010 | 6480464 | Diethylnitrosamine results in increased expression of LIPE mRNA | CTD | PMID:20360939 | nicotinic acid | decreases activity | ISO | RGD:737132 | 6480464 | Niacin results in decreased activity of LIPE protein | CTD | PMID:14749208 | nicotinic acid | decreases expression | ISO | RGD:737132 | 6480464 | Niacin results in decreased expression of LIPE mRNA | CTD | PMID:19131065 | ozone | decreases expression | EXP | | 6480464 | Ozone results in decreased expression of LIPE mRNA | CTD | PMID:12763052 | ozone | multiple interactions | ISO | RGD:3010 | 6480464 | [Ozone co-treated with Chlorine] results in increased expression of LIPE mRNA | CTD | PMID:18636392 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LIPE mRNA | CTD | PMID:19710929 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of LIPE mRNA | CTD | PMID:17426115 PMID:18301758 | pirinixic acid | increases expression | ISO | RGD:3010 | 6480464 | pirinixic acid results in increased expression of LIPE mRNA | CTD | PMID:19162173 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of LIPE mRNA | CTD | PMID:18301758 PMID:17426115 | resveratrol | decreases expression | ISO | RGD:3010 | 6480464 | resveratrol results in decreased expression of LIPE mRNA | CTD | PMID:21569266 | rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of LIPE mRNA | CTD | PMID:18643838 | rosiglitazone | increases expression | ISO | RGD:3010 | 6480464 | rosiglitazone results in increased expression of LIPE mRNA | CTD | PMID:15887043 PMID:21515302 | rosiglitazone | increases expression | ISO | RGD:3010 | 6480464 | rosiglitazone results in increased expression of LIPE mRNA | CTD | PMID:15887043 | rosiglitazone | multiple interactions | ISO | RGD:3010 | 6480464 | rosiglitazone results in increased expression of and results in increased activity of LIPE protein | CTD | PMID:15887043 | rosiglitazone | affects expression | EXP | | 6480464 | rosiglitazone affects the expression of LIPE mRNA | CTD | PMID:22013433 | rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Ethanol results in increased expression of LIPE mRNA] | CTD | PMID:22173916 | sirolimus | multiple interactions | EXP | | 6480464 | Sirolimus promotes the reaction [Isoproterenol results in increased phosphorylation of LIPE protein] | CTD | PMID:21042876 | streptozocin | multiple interactions | ISO | RGD:3010 | 6480464 | vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of LIPE mRNA] | CTD | PMID:16684804 | streptozocin | increases expression | ISO | RGD:3010 | 6480464 | Streptozocin results in increased expression of LIPE mRNA | CTD | PMID:16684804 | tamoxifen | decreases expression | EXP | | 6480464 | Tamoxifen results in decreased expression of LIPE mRNA | CTD | PMID:20937368 | telmisartan | multiple interactions | EXP | | 6480464 | PPARD promotes the reaction [telmisartan results in increased expression of LIPE protein] | CTD | PMID:20176998 | telmisartan | increases expression | EXP | | 6480464 | telmisartan results in increased expression of LIPE protein | CTD | PMID:20176998 | theophylline | multiple interactions | ISO | RGD:737132 | 6480464 | Theophylline inhibits the reaction [Epinephrine results in increased activity of LIPE protein] | CTD | PMID:7155675 | theophylline | affects localization | ISO | RGD:3010 | 6480464 | Theophylline affects the localization of LIPE protein | CTD | PMID:11160373 | theophylline | increases activity | ISO | RGD:737132 | 6480464 | Theophylline results in increased activity of LIPE protein | CTD | PMID:7155675 | trans-resveratrol | decreases expression | ISO | RGD:3010 | 6480464 | resveratrol results in decreased expression of LIPE mRNA | CTD | PMID:21569266 | troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of LIPE mRNA | CTD | PMID:12732648 | troglitazone | increases expression | ISO | RGD:3010 | 6480464 | troglitazone results in increased expression of LIPE mRNA | CTD | PMID:21515302 | vanadyl sulfate | multiple interactions | ISO | RGD:3010 | 6480464 | vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of LIPE mRNA] | CTD | PMID:16684804 | zidovudine | affects expression | ISO | RGD:737132 | 6480464 | Zidovudine affects the expression of LIPE mRNA | CTD | PMID:20032539 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gene Ontology Annotations
Molecular Pathway Annotations| External Database Links | |
| KEGG Pathway | Insulin signaling pathway |
Phenotype Annotations
Disease Annotations
|
|
Gene-Chemical Interaction Annotations
|
|
|
Gene Ontology Annotations
|
|
|
|
|
|
Molecular Pathway Annotations
Phenotype Annotations
|
|
|
References - curated| 1. |
Bernard N, etal., J Hum Genet. 2007;52(3):244-54. Epub 2007 Feb 15. |
| 2. |
Harte RA, etal., Atherosclerosis. 2000 Apr;149(2):343-50. |
| 3. |
Holst LS, etal., Genomics 1996 Aug 1;35(3):441-7. |
| 4. |
Jonassen T, etal., Arch Biochem Biophys 1996 Jun 15;330(2):285-9. |
| 5. |
Kawai J, etal., Nature 2001 Feb 8;409(6821):685-90. |
| 6. |
Ma W, etal., Wei Sheng Yan Jiu. 2007 May;36(3):320-2. |
| 7. |
MGD and Homologene mouse data transfer |
| 8. |
MGD data from the GO Consortium |
| 9. |
MGD IEA |
| 10. |
Okazaki Y, etal., Nature 2002 Dec 5;420(6915):563-73. |
| 11. |
Pipeline to import KEGG annotations from KEGG into RGD Pathway Ontology |
| 12. |
RGD automated import pipeline |
| 13. |
RGD automated import pipeline for gene-chemical interactions |
| 14. |
Scribner KA, etal., Metabolism. 2000 Sep;49(9):1106-10. |
| 15. |
Ueno M, etal., Am J Physiol Endocrinol Metab. 2008 Jun;294(6):E1109-18. Epub 2008 Apr 15. |
| 16. |
Warden CH, etal., Genomics 1993 Nov;18(2):295-307. |
| 17. |
Watt MJ, etal., Diabetologia. 2005 Jan;48(1):105-12. Epub 2004 Dec 18. |
References - uncurated| PubMed | 10349636 |
| 10639158 | |
| 11042159 | |
| 11063252 | |
| 11076861 | |
| 11076952 | |
| 11316346 | |
| 11440986 | |
| 11522661 | |
| 11551864 | |
| 11564684 | |
| 11717312 | |
| 11751901 | |
| 11809748 | |
| 12040188 | |
| 12193545 | |
| 12477932 | |
| 12482847 | |
| 12832420 | |
| 12835327 | |
| 12865325 | |
| 12923228 | |
| 12954598 | |
| 13129924 | |
| 14643795 | |
| 14657254 | |
| 14752112 | |
| 15142983 | |
| 15220197 | |
| 15242332 | |
| 15271647 | |
| 15292223 | |
| 15345679 | |
| 15550674 | |
| 15701680 | |
| 15878856 | |
| 15961788 | |
| 16091387 | |
| 16141072 | |
| 16141073 | |
| 16199803 | |
| 16243839 | |
| 16765472 | |
| 16804080 | |
| 16985254 | |
| 17026959 | |
| 17074755 | |
| 17114792 | |
| 17134676 | |
| 17215164 | |
| 17711991 | |
| 17886267 | |
| 18335062 | |
| 18337240 | |
| 18480494 | |
| 18492774 | |
| 18572100 | |
| 18664600 | |
| 18804448 | |
| 18824087 | |
| 19023560 | |
| 19246492 | |
| 19491295 | |
| 19515989 | |
| 19619509 | |
| 19706782 | |
| 19723498 | |
| 19755426 | |
| 19785415 | |
| 20107043 | |
| 20143880 | |
| 20435159 | |
| 20534721 | |
| 20625037 | |
| 20950707 | |
| 21111707 | |
| 21180279 | |
| 21241784 | |
| 21267068 | |
| 21464445 | |
| 21505145 | |
| 21543206 | |
| 21566206 | |
| 21677750 | |
| 21680814 | |
| 21738729 | |
| 21857651 | |
| 21969372 | |
| 22842588 | |
| 22988039 | |
| 23066022 | |
| 23431266 | |
| 23471217 | |
| 7560076 | |
| 7698747 | |
| 7698777 | |
| 8104872 | |
| 8105016 | |
| 8263420 | |
| 8798769 | |
| 8827514 | |
| 9060404 | |
| 9077551 | |
| 9173930 | |
| 9446609 | |
| 9582279 | |
| 9615220 |
RGD Disease Portals| Lipe has been annotated in the following RGD Disease Portals. |
|||||||||
![]() |
| ||||||||
![]() |
| ||||||||
![]() |
| ||||||||
![]() |
| ||||||||
![]() |
| ||||||||
![]() |
| ||||||||
![]() |
| ||||||||
Comparative Map Data| Lipe (Mus musculus) |
|
|||||||||||||||||||||||||||||||||||
| LIPE (Homo sapiens) |
|
|||||||||||||||||||||||||||||||||||
| Lipe (Rattus norvegicus) |
|
Position Markers| RH131319 |
|
|||||||||||||||||||||||||||||||||||
| U69543 |
|
QTLs in Region (Mouse Genome Assembly Build 37)| The following QTLs overlap with this region. | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer | ![]() | Gviewer |
Nucleotide Sequences| Nucleotide RefSeqs | NM_001039507 | (Get FASTA) | Search GEO for Microarray Profiles |
| NM_010719 | (Get FASTA) | Search GEO for Microarray Profiles | |
| GenBank Nucleotide | AAHY01059999 | (Get FASTA) | Search GEO for Microarray Profiles |
| AC162443 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AC169209 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AF179427 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AF452490 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AK016633 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AK019846 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AK029984 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AK169858 | (Get FASTA) | Search GEO for Microarray Profiles | |
| BC021642 | (Get FASTA) | Search GEO for Microarray Profiles | |
| BC053502 | (Get FASTA) | Search GEO for Microarray Profiles | |
| BY513432 | (Get FASTA) | Search GEO for Microarray Profiles | |
| CAAA01163929 | (Get FASTA) | Search GEO for Microarray Profiles | |
| CH466593 | (Get FASTA) | Search GEO for Microarray Profiles | |
| U08187 | (Get FASTA) | Search GEO for Microarray Profiles | |
| U08188 | (Get FASTA) | Search GEO for Microarray Profiles | |
| U12765 | (Get FASTA) | Search GEO for Microarray Profiles |
| RefSeq Acc Id: | NM_010719 | |||||||||||||||||||||||||
| RefSeq Status: | VALIDATED | |||||||||||||||||||||||||
| Type: | CODING | |||||||||||||||||||||||||
| Protein Acc Id: | NP_034849 | |||||||||||||||||||||||||
| Peptide Label: | isoform 1 | |||||||||||||||||||||||||
| Position: |
|
| RefSeq Acc Id: | NM_001039507 | |||||||||||||||||||||||||
| RefSeq Status: | VALIDATED | |||||||||||||||||||||||||
| Type: | CODING | |||||||||||||||||||||||||
| Protein Acc Id: | NP_001034596 | |||||||||||||||||||||||||
| Peptide Label: | isoform 2 | |||||||||||||||||||||||||
| Position: |
|
| RefSeq Acc Id: | XM_003086575 |
| RefSeq Status: | |
| Type: | CODING |
| Position: | No map positions available. |
| RefSeq Acc Id: | XM_003084674 | ||||||||||
| RefSeq Status: | |||||||||||
| Type: | CODING | ||||||||||
| Position: |
|
| RefSeq Acc Id: | XM_003689404 |
| RefSeq Status: | |
| Type: | CODING |
| Protein Acc Id: | XP_003689452 |
| Position: | No map positions available. |
| RefSeq Acc Id: | XM_003688825 |
| RefSeq Status: | |
| Type: | CODING |
| Protein Acc Id: | XP_003688873 |
| Position: | No map positions available. |
Protein Sequences| Protein RefSeqs | NP_001034596 | (Get FASTA) |
| NP_034849 | (Get FASTA) | |
| GenBank Protein | AAA50232 | (Get FASTA) |
| AAC52163 | (Get FASTA) | |
| AAC53069 | (Get FASTA) | |
| AAH21642 | (Get FASTA) | |
| AAP84985 | (Get FASTA) | |
| BAB30349 | (Get FASTA) | |
| BAB31878 | (Get FASTA) | |
| BAC26716 | (Get FASTA) | |
| BAE41414 | (Get FASTA) | |
| EDL24271 | (Get FASTA) | |
| EDL24272 | (Get FASTA) | |
| P54310 | (Get FASTA) |
Promoters| RGD ID: | 6840262 | ||||||||||
| Promoter ID: | MM_KWN:49446 | ||||||||||
| Type: | CpG-Island | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | MPROMDB | ||||||||||
| Tissues & Cell Lines: | 3T3L1_Day1, 3T3L1_Day2, 3T3L1_Day3, 3T3L1_Day4, 3T3L1_Day6, BoneMarrow_0Hour, Brain, ES_Cell, Kidney, MEF_B6 | ||||||||||
| Transcripts: | AK076372_4732471J01RIK, UC009FSN.1 | ||||||||||
| Position: |
|
| RGD ID: | 6848161 | ||||||||||
| Promoter ID: | MM_ACW:43895 | ||||||||||
| Type: | CpG-Island | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | MPROMDB | ||||||||||
| Tissues & Cell Lines: | 3T3L1_Day3, 3T3L1_Day4, 3T3L1_Day6, BoneMarrow_2Hour, ES_Cell | ||||||||||
| Transcripts: | LIPE.GSEP07-UNSPLICED | ||||||||||
| Position: |
|
| RGD ID: | 6848162 | ||||||||||
| Promoter ID: | MM_ACW:43896 | ||||||||||
| Type: | Non-CpG | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | MPROMDB | ||||||||||
| Tissues & Cell Lines: | 3T3L1_Day2, 3T3L1_Day3, 3T3L1_Day4, Brain, Kidney | ||||||||||
| Transcripts: | LIPE.HSEP07 | ||||||||||
| Position: |
|
| RGD ID: | 6848200 | ||||||||||
| Promoter ID: | MM_ACW:43897 | ||||||||||
| Type: | CpG-Island | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | MPROMDB | ||||||||||
| Tissues & Cell Lines: | 3T3L1_Day3, 3T3L1_Day4, Brain, Kidney | ||||||||||
| Transcripts: | LIPE.FSEP07, MIROTE.ESEP07 | ||||||||||
| Position: |
|
| RGD ID: | 6841447 | ||||||||||
| Promoter ID: | MM_KWN:49447 | ||||||||||
| Type: | Non-CpG | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | MPROMDB | ||||||||||
| Tissues & Cell Lines: | 3T3L1_Day1, 3T3L1_Day2, 3T3L1_Day3, 3T3L1_Day4, 3T3L1_Day6, Brain, Kidney, Lung | ||||||||||
| Transcripts: | UC009FSP.1 | ||||||||||
| Position: |
|
| RGD ID: | 6841446 | ||||||||||
| Promoter ID: | MM_KWN:49448 | ||||||||||
| Type: | Non-CpG | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | MPROMDB | ||||||||||
| Tissues & Cell Lines: | 3T3L1_Day1, 3T3L1_Day2, 3T3L1_Day3, 3T3L1_Day4, 3T3L1_Day6, Brain, Liver | ||||||||||
| Transcripts: | NM_001039507 | ||||||||||
| Position: |
|
| RGD ID: | 6880662 | ||||||||||
| Promoter ID: | EPDNEW_M3782 | ||||||||||
| Type: | preliminary | ||||||||||
| Name: | Lipe_1 | ||||||||||
| Description: | lipase, hormone sensitive | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||||
| Position: |
|
| RGD ID: | 6841445 | ||||||||||
| Promoter ID: | MM_KWN:49450 | ||||||||||
| Type: | CpG-Island | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | MPROMDB | ||||||||||
| Tissues & Cell Lines: | BoneMarrow_0Hour, Brain, ES_Cell, Kidney, Lung, Spleen | ||||||||||
| Transcripts: | NM_010719, UC009FSS.1 | ||||||||||
| Position: |
|
External Database Links| Database | Acc Id | Source(s) |
| Ensembl Genes | ENSMUSG00000003123 | ENTREZGENE |
| Ensembl Protein | ENSMUSP00000003207 | ENTREZGENE |
| ENSMUSP00000050935 | ENTREZGENE | |
| Ensembl Transcript | ENSMUST00000003207 | ENTREZGENE |
| ENSMUST00000054301 | ENTREZGENE | |
| Entrez Gene | 16890 | ENTREZGENE |
| Germonline | ENSMUSG00000003123 | |
| HomoloGene Group ID | 3912 | ENTREZGENE |
| InterPro | AB_hydrolase_3 | UniProtKB/Swiss-Prot |
| HSL_N | UniProtKB/Swiss-Prot | |
| Lipase_GDXG_AS | UniProtKB/Swiss-Prot | |
| KEGG Report | mmu:101055998 | UniProtKB/TrEMBL |
| mmu:16890 | ENTREZGENE, UniProtKB/Swiss-Prot | |
| MGD | MGI:96790 | ENTREZGENE |
| Pfam | Abhydrolase_3 | UniProtKB/Swiss-Prot |
| HSL_N | UniProtKB/Swiss-Prot | |
| PROSITE | LIPASE_GDXG_HIS | UniProtKB/Swiss-Prot |
| LIPASE_GDXG_SER | UniProtKB/Swiss-Prot | |
| UniGene | Mm.158548 | ENTREZGENE |
| Mm.333679 | ENTREZGENE | |
| UniProt | E9Q4M2_MOUSE | UniProtKB/TrEMBL |
| LIPS_MOUSE | UniProtKB/Swiss-Prot | |
| Q8CDI9_MOUSE | UniProtKB/TrEMBL | |
| Q9CTW2_MOUSE | UniProtKB/TrEMBL | |
| Q9D4C4_MOUSE | UniProtKB/TrEMBL |
| More on Lipe | |
![]() |
Entrez Gene |
![]() |
Ensembl Gene |
![]() | Genome Browser |
![]() |
MGI Report |
![]() |
NCBI Map Viewer |
![]() |
Vista |
![]() |
Vista + UCSC |
| RGD Object Information | |
| RGD ID: | 10872 |
| Created: | 2000-05-25 |
| Species: | Mus musculus |
| Last Modified: | 2013-05-14 |
| Status: | ACTIVE |
© Bioinformatics Program, HMGC at the Medical College of Wisconsin
RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.




